Leap Therapeutics (LPTX) Stock Highlights

2.59 | -4.07%

2024-11-21 05:44:49

Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1. DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. The company is studying DKN-01 in multiple ongoing clinical trials in patients with esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, or prostate cancer. Its other clinical studies include P100, P102, P204,and P205.

Statistics

Range Today

2.55 2.7

Volume Today 208.8K

Range 1 Year

1.68 5

Volume 1 Year 62.6M

Range 3 Year

1.24 34.49

Volume 3 Year 128.94M

Range 10 Year

1.24 161

Volume 10 Year 227.35M

Highlights

Market Capitalization 123.98M (small)

Floating Shares 26.09M

Current Price 2.59

Price To Earnings -3.52

Price To Book 1.88

Earnings Per Share -0.98

Payout Ratio 0%

Performance

Latest -4.07%

1 Month -3.36%

3 Months +1.17%

6 Months -1.52%

1 Year +40%

3 Years -88.23%

5 Years -67.22%

10 Years -96.5%

Benchmarks

Market Capitalization

277 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

178 / 368

Free Cashflow

211 / 352

Performance 5 years

216 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.